biotech
biotech Articles
Correvio Pharma shares were crushed after the firm announced the FDA Cardiovascular and Renal Drugs Advisory Committee decision for its New Drug Application seeking approval for Brinavess. This could...
Published:
Proteostasis shares jumped on Wednesday after the firm announced positive, initial ex-vivo results of its proprietary cystic fibrosis transmembrane conductance regulator modulators, PTI-801, PTI-808...
Published:
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Dermira shares jumped on Tuesday after the firm announced that the FDA has granted Fast Track designation for lebrikizumab, its treatment moderate-to-severe atopic dermatitis.
Published:
Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal...
Published:
Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some. The biotechnology sector is pushing near all-time highs, and a few of...
Published:
Sage Therapeutics shareholders took a bath on Thursday after results from its late-stage major depressive disorder trial came public.
Published:
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Published:
Protagonist Therapeutics shares jumped on Wednesday after the company announced preliminary results from its midstage study for patients with transfusion-dependent beta-thalassemia.
Published:
Audentes Therapeutics shares more than doubled on Tuesday after the firm announced that it would be acquired by Astellas. Although Audentes has only been public for just over three years, this...
Published:
Aslan Pharmaceuticals has been on a roller coaster for the past two weeks. Now the stock is coming back to earth, with the company announcing that it will be capitalizing on these gains with a...
Published:
Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic kidney disease.
Published:
Axsome Therapeutics shares jumped early on Tuesday after the firm announced positive results from its midstage narcolepsy trial.
Published:
Aslan Pharmaceuticals shares jumped on Monday after the firm announced positive preliminary data from the lowest dose cohort of its ongoing multiple ascending dose study of its treatment of...
Published:
Aquestive Therapeutics shares jumped early on Monday after the firm announced the completion of its rolling submission of a New Drug Application (NDA) to the FDA for its therapeutic candidate...
Published: